Finland· FI-REL-REL7704

Terra-Poly Vet

A oksitetrasykliiniä sisältävät yhdistelmävalmisteet product, registered in Finland by Pfizer Service Company BVBA.

ATC QJ01AA56

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedTerra-Poly VetATCQJ01AA56REGISTER NO.FI-REL-REL7704PACKS LISTED0CHECKEDSeptember 27, 2026

The record

At a glance

Fimea (Finland)
Manufacturer
Pfizer Service Company BVBA
Country
Finland (FI)
ATC code
QJ01AA56
ATC class
Oksitetrasykliiniä sisältävät yhdistelmävalmisteet
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under QJ01AA56

Oksitetrasykliiniä sisältävät yhdistelmävalmisteet, as other registers publish it.

All Terra-Poly products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d232ad67-beae-45ae-b05e-a7389825d0be
GET /v1/drugs/d232ad67-beae-45ae-b05e-a7389825d0be?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": null,
  "form": "tabletti",
  "route": null,
  "ddd_unit": null,
  "strength": null,
  "atc_label": "Oksitetrasykliiniä sisältävät yhdistelmävalmisteet",
  "ma_number": "3340",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL7704",
  "authorised_at": "1966-04-27"
}

See everything about Terra-Poly.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.